Ali Tehrani
Fondateur chez Student Biotechnology Network
Fortune : 3 M $ au 30/04/2024
Postes actifs de Ali Tehrani
Sociétés | Poste | Début | Fin |
---|---|---|---|
Student Biotechnology Network | Directeur/Membre du Conseil | - | - |
Fondateur | - | - | |
Consortium Québécois sur la Découverte du Médicament
Consortium Québécois sur la Découverte du Médicament Miscellaneous Commercial ServicesCommercial Services Consortium Québécois sur la Découverte du Médicament (CQDM) is a not-for-profit biopharmaceutical research consortium based in Montréal, Canada. CQDM's mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy. CQDM funds the development of innovative tools and technologies that accelerate the discovery and development of safer and more effective drugs. The company's Quantum Leap pharma-led funding program for drug discovery research helps SMEs or Canadian universities achieve innovative translational biopharmaceutical research projects. CQDM's SynergiQC-International program is designed to promote university-based industrial research in the biopharmaceutical field with collaborators outside, that will generate economic benefits. The non-profit company was founded by Max Fehlmann. | Directeur/Membre du Conseil | - | - |
Creatus Biosciences, Inc.
Creatus Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Creatus Biosciences, Inc. operates as an industrial biotechnology company specializing in yeast genetic design and development. The company was founded in 2014 and is headquartered in Vancouver, Canada. | Directeur/Membre du Conseil | 01/01/2015 | - |
BIOTECanada
BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Directeur/Membre du Conseil | 03/06/2021 | - |
Amplitude Ventures
Amplitude Ventures Investment ManagersFinance Amplitude Ventures is a venture capital firm. The firm was founded in 2018. It’s headquartered in Montreal, Canada. | Private Equity Investor | 01/03/2022 | - |
Consultant / Advisor | 01/09/2020 | 01/03/2022 | |
Reverb Therapeutics | Directeur/Membre du Conseil | 01/07/2023 | - |
Qurcan Therapeutics, Inc. | Directeur/Membre du Conseil | 01/01/2022 | - |
Historique de carrière de Ali Tehrani
Anciens postes connus de Ali Tehrani
Sociétés | Poste | Début | Fin |
---|---|---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Directeur/Membre du Conseil | 08/09/2003 | 15/01/2022 |
Directeur Général | 08/09/2003 | 15/01/2022 | |
Fondateur | 08/09/2003 | 15/01/2022 | |
President | 08/09/2003 | 15/01/2022 | |
ZYMEWORKS INC. | Directeur Général | 01/01/2013 | 15/01/2022 |
President | 01/01/2013 | 15/01/2022 | |
░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formation de Ali Tehrani
University of Massachusetts | Graduate Degree |
University of British Columbia | Doctorate Degree |
Statistiques
Internationale
Canada | 12 |
Etats-Unis | 3 |
Opérationnelle
Director/Board Member | 8 |
Chief Executive Officer | 2 |
Founder | 2 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ZYMEWORKS INC. | Health Technology |
Entreprise privées | 10 |
---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
LifeSciences British Columbia
LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Health Technology |
Student Biotechnology Network | |
Consortium Québécois sur la Découverte du Médicament
Consortium Québécois sur la Découverte du Médicament Miscellaneous Commercial ServicesCommercial Services Consortium Québécois sur la Découverte du Médicament (CQDM) is a not-for-profit biopharmaceutical research consortium based in Montréal, Canada. CQDM's mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy. CQDM funds the development of innovative tools and technologies that accelerate the discovery and development of safer and more effective drugs. The company's Quantum Leap pharma-led funding program for drug discovery research helps SMEs or Canadian universities achieve innovative translational biopharmaceutical research projects. CQDM's SynergiQC-International program is designed to promote university-based industrial research in the biopharmaceutical field with collaborators outside, that will generate economic benefits. The non-profit company was founded by Max Fehlmann. | Commercial Services |
Creatus Biosciences, Inc.
Creatus Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Creatus Biosciences, Inc. operates as an industrial biotechnology company specializing in yeast genetic design and development. The company was founded in 2014 and is headquartered in Vancouver, Canada. | Commercial Services |
Premier's Technology Council | Government |
BIOTECanada
BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Health Technology |
Amplitude Ventures
Amplitude Ventures Investment ManagersFinance Amplitude Ventures is a venture capital firm. The firm was founded in 2018. It’s headquartered in Montreal, Canada. | Finance |
Reverb Therapeutics | |
Qurcan Therapeutics, Inc. |
- Bourse
- Insiders
- Ali Tehrani
- Expérience